CGON Reports $742.2M Cash, $903.0M Liquidity, PIVOT-006 1H'26 Data, CORE-008 CX Results 1H'26
CG Oncology, Inc. Common stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $59.23
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS